Papillary Tumor of the Pineal Region: Systematic Review and Analysis of Prognostic Factors

Nenhuma Miniatura disponível
Citações na Scopus
21
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
OXFORD UNIV PRESS INC
Citação
NEUROSURGERY, v.85, n.3, p.E420-E429, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND Clinical outcomes and biological behavior of papillary tumors of the pineal region (PTPR) are still under investigation. The best therapeutic strategy has not been defined. OBJECTIVE To perform a comprehensive patient-level analysis of all PTPR cases and identify their clinical features, treatment options, and prognostic factors. METHODS A search of the medical databases for case series and reports on PTPRs from January 2003 to June 2017 was performed. Data addressing PTPR's clinical presentation, imaging, treatment, and histological features were. Variables associated with the primary outcome of 36-mo survival were identified through Cox regression models. RESULTS The initial search yielded 1164 studies, of which 71 were included (60 case reports and 11 case series), containing 177 patients (mean age 33.0 15.3 yr and 53.2% male). Intracranial hypertension and hydrocephalus prevailed as the clinical picture. Surgery was performed on 82.0% and gross total resection (GTR) was achieved on 71.4%. A total of 56.8% recurred after a median 29 mo (quartiles 10.5-45.5). The 36-mo survival rate was 83.5% (95% confidence interval [CI] 76.2-89.2%). Good functional outcomes (Glasgow Outcome Scale 4/5) were observed in 60.0%. The variables of interest were inconsistently reported and the multivariable analysis final sample was 133 patients. After adjustment for age, tumor size (each additional centimeter, hazard ratio [HR] 1.99, 95% CI 1.12-3.53, P = .019) and surgical treatment (HR 0.16, 95% CI 0.05-0.45, P = .001) were associated with 36-mo survival. CONCLUSION Tumor size and surgery are associated with improvement in 36-mo survival. We did not observe any significant benefits from GTR or adjuvant treatments.
Palavras-chave
Brain neoplasms, Pineal gland, Papillary tumor of the pineal region, Systematic review, Meta-analysis
Referências
  1. Abela L, 2013, CHILD NERV SYST, V29, P307, DOI 10.1007/s00381-012-1935-1
  2. Aggarwal Sushil Kumar, 2016, Asian J Neurosurg, V11, P78, DOI 10.4103/1793-5482.172592
  3. Alkhotani A, 2014, BRAIN PATHOL, V24, P191, DOI 10.1111/bpa.12121
  4. Boco T, 2008, NEUROPATHOLOGY, V28, P87, DOI 10.1111/j.1440-1789.2007.00832.x
  5. Buffenoir K, 2008, CHILD NERV SYST, V24, P379, DOI 10.1007/s00381-007-0500-9
  6. Cardenas R, 2010, NEUROL INDIA, V58, P471, DOI 10.4103/0028-3886.66051
  7. Cerase A, 2009, J NEURO-ONCOL, V95, P433, DOI 10.1007/s11060-009-9931-3
  8. Chang AH, 2008, AM J NEURORADIOL, V29, P187, DOI 10.3174/ajnr.A0784
  9. Chatterjee D, 2015, NEUROL INDIA, V63, P567, DOI 10.4103/0028-3886.162055
  10. Cimino PJ, 2015, NEUROSURGERY, V77, P621, DOI 10.1227/NEU.0000000000000877
  11. Coello AF, 2009, NEUROLOGY, V73, P486, DOI 10.1212/WNL.0b013e3181b16637
  12. Cohan JN, 2011, J NEURO-ONCOL, V101, P301, DOI 10.1007/s11060-010-0242-5
  13. Cohen AL, 2013, CASE REP ONCOL, V6, P434, DOI 10.1159/000354753
  14. Cykowski MD, 2012, ULTRASTRUCT PATHOL, V36, P68, DOI 10.3109/01913123.2011.620222
  15. Dagnew E, 2007, NEUROSURGERY, V60, P953, DOI 10.1227/01.NEU.0000255443.44365.77
  16. Deiana G, 2015, NEUROCHIRURGIE, V61, P113, DOI 10.1016/j.neuchi.2014.10.111
  17. Dhillon J, 2010, CYTOPATHOLOGY, V21, P267, DOI 10.1111/j.1365-2303.2009.00696.x
  18. Edson MA, 2015, WORLD NEUROSURG, V84, P76, DOI 10.1016/j.wneu.2015.02.031
  19. El Majdoub F, 2012, J NEURO-ONCOL, V109, P99, DOI 10.1007/s11060-012-0870-z
  20. Epari S, 2011, NEUROL INDIA, V59, P455, DOI 10.4103/0028-3886.82773
  21. Ersahin Y, 2005, J NEUROSURG, V102, P137
  22. Fauchon F, 2013, J NEURO-ONCOL, V112, P223, DOI 10.1007/s11060-013-1050-5
  23. Fevre-Montange M, 2008, NEUROPATHOLOGY, V28, P660, DOI 10.1111/j.1440-1789.2008.00906.x
  24. Fevre-Montange M, 2006, J NEUROPATH EXP NEUR, V65, P1004, DOI 10.1097/01.jnen.0000240462.80263.13
  25. Gutenberg A, 2011, BRAIN PATHOL, V21, P672, DOI 10.1111/j.1750-3639.2011.00493.x
  26. Hasselblatt M, 2006, NEUROPATH APPL NEURO, V32, P278, DOI 10.1111/j.1365-2990.2006.00723.x
  27. Heim S, 2016, BRAIN PATHOL, V26, P199, DOI 10.1111/bpa.12282
  28. Heim S, 2014, AM J SURG PATHOL, V38, P106, DOI 10.1097/PAS.0b013e31829e492d
  29. Heim S, 2013, J NEURO-ONCOL, V115, P127, DOI 10.1007/s11060-013-1202-7
  30. Hong BJ, 2011, CLIN NEUROL NEUROSUR, V113, P235, DOI 10.1016/j.clineuro.2010.10.010
  31. Hua XM, 2015, EXP THER MED, V10, P1375, DOI 10.3892/etm.2015.2696
  32. Husain N, 2009, NEUROL INDIA, V57, P792, DOI 10.4103/0028-3886.59481
  33. Iacoangeli M, 2017, ACTA NEUROCHIR, V159, P645, DOI 10.1007/s00701-017-3117-0
  34. Inoue T, 2008, BRAIN TUMOR PATHOL, V25, P85, DOI 10.1007/s10014-008-0231-y
  35. Ishida A, 2013, BRAIN TUMOR PATHOL, V30, P45, DOI 10.1007/s10014-012-0098-9
  36. Jeruc J PM, 2008, CLIN NEUROPATHOL, V27, P192
  37. Jimenez-Heffernan JA, 2016, DIAGN CYTOPATHOL, V44, P1098, DOI 10.1002/dc.23560
  38. Jouvet A, 2003, AM J SURG PATHOL, V27, P505, DOI 10.1097/00000478-200304000-00011
  39. Kaloostian PE, 2013, AM J CASE REP, V14, P164, DOI 10.12659/AJCR.883919
  40. Kaloshi G, 2010, J NEURO-ONCOL, V100, P487, DOI 10.1007/s11060-010-0198-5
  41. Kamamoto D, 2016, BRAIN TUMOR PATHOL, V33, P271, DOI 10.1007/s10014-016-0270-8
  42. Kawahara I, 2007, NEUROL MED-CHIR, V47, P568, DOI 10.2176/nmc.47.568
  43. Kern M, 2006, CLIN NEUROPATHOL, V25, P185
  44. Kim YH, 2010, NEUROPATHOLOGY, V30, P654, DOI 10.1111/j.1440-1789.2010.01108.x
  45. Konovalov AN, 2003, SURG NEUROL, V59, P250, DOI 10.1016/S0090-3019(03)00080-6
  46. Koziarski A, 2014, NEUROL NEUROCHIR POL, V48, P356, DOI 10.1016/j.pjnns.2014.09.005
  47. Kuchelmeister K, 2006, NEUROPATH APPL NEURO, V32, P203, DOI 10.1111/j.1365-2990.2006.00741.x
  48. Lechapt-Zalcman E, 2011, NEUROPATH APPL NEURO, V37, P431, DOI 10.1111/j.1365-2990.2010.01133.x
  49. Li J, 2011, J NEUROSURG-PEDIATR, V7, P534, DOI 10.3171/2011.2.PEDS10434
  50. Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4
  51. Magalhaes J, 2013, BRAIN TUMOR PATHOL, V30, P93, DOI 10.1007/s10014-012-0103-3
  52. Matyja E, 2011, FOLIA NEUROPATHOL, V49, P181
  53. Mbekeani Joyce N, 2015, Hematol Oncol Stem Cell Ther, V8, P140, DOI 10.1016/j.hemonc.2015.06.002
  54. Mobley BC, 2015, HUM PATHOL, V46, P1232, DOI 10.1016/j.humpath.2015.04.014
  55. Montange MF, 2015, NEUROCHIRURGIE, V61, P138, DOI 10.1016/j.neuchi.2013.04.011
  56. Montange MF, 2012, AM J SURG PATHOL, V36, P916, DOI 10.1097/PAS.0b013e31824b7114
  57. Mottolese C, 2015, NEUROCHIRURGIE, V61, P65, DOI 10.1016/j.neuchi.2014.01.005
  58. Mottolese C, 2015, NEUROCHIRURGIE, V61, P176, DOI 10.1016/j.neuchi.2014.02.004
  59. Mottolese C, 2015, NEUROCHIRURGIE, V61, P223, DOI 10.1016/j.neuchi.2014.02.006
  60. Murali R, 2010, PATHOLOGY, V42, P474, DOI 10.3109/00313025.2010.494292
  61. Nakamura H, 2009, BRAIN TUMOR PATHOL, V26, P73, DOI 10.1007/s10014-009-0250-3
  62. Nowicka E, 2016, FOLIA NEUROPATHOL, V54, P72, DOI 10.5114/fn.2016.58918
  63. Patil Meena, 2016, Asian J Neurosurg, V11, P453
  64. Poulgrain K, 2011, J CLIN NEUROSCI, V18, P1007, DOI 10.1016/j.jocn.2010.12.027
  65. Rickard KA, 2011, ANN CLIN LAB SCI, V41, P174
  66. Riis P, 2013, STEREOT FUNCT NEUROS, V91, P186, DOI 10.1159/000344023
  67. Roncaroli F, 2007, BRAIN PATHOL, V17, P314, DOI 10.1111/j.1750-3639.2007.00081.x
  68. Santarius T, 2008, BRIT J NEUROSURG, V22, P116, DOI 10.1080/02688690701583794
  69. Santoro A, 2012, NEUROL SCI, V33, P931, DOI 10.1007/s10072-011-0860-5
  70. Sato TS, 2009, PEDIATR RADIOL, V39, P188, DOI 10.1007/s00247-008-1060-1
  71. Shakir H, 2015, SURG NEUROL INT, V6, P451
  72. Sharma MC, 2009, CLIN NEUROPATHOL, V28, P295
  73. Shibahara J, 2004, ACTA NEUROPATHOL, V108, P337, DOI 10.1007/s00401-004-0898-z
  74. Shiramizu H, 2013, NEUROSURG REV, V36, P467, DOI 10.1007/s10143-013-0455-0
  75. Sun IS, 2015, ACTA NEUROCHIR, V157, P215, DOI 10.1007/s00701-014-2308-1
  76. Vaghela V, 2010, Neurol India, V58, P928, DOI 10.4103/0028-3886.73750
  77. Vandergriff Clayton, 2012, Proc (Bayl Univ Med Cent), V25, P78
  78. Varikatt W, 2009, NEUROPATHOLOGY, V29, P641, DOI 10.1111/j.1440-1789.2009.01038.x
  79. Vieira G, 2011, BRAIN TUMOR PATHOL, V28, P329, DOI 10.1007/s10014-011-0040-6
  80. Wong YS, 2012, BRAIN PATHOL, V22, P255, DOI 10.1111/j.1750-3639.2012.00570.x
  81. Yano H, 2009, BRAIN TUMOR PATHOL, V26, P83, DOI 10.1007/s10014-009-0246-z